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OBJECTIVE—Low-fat hypocaloric diets reduce insulin resis-
tance and prevent type 2 diabetes in those at risk. Low-
carbohydrate, high-fat diets are advocated as an alternative,
but reciprocal increases in dietary fat may have detrimental
effects on insulin resistance and offset the beneﬁts of weight
reduction.
RESEARCH DESIGN AND METHODS—We investigated a
low-fat (20% fat, 60% carbohydrate) versus a low-carbohydrate
(60% fat, 20% carbohydrate) weight reduction diet in 24 over-
weight/obese subjects ([mean  SD] BMI 33.6  3.7 kg/m
2, aged
39  10 years) in an 8-week randomized controlled trial. All food
was weighed and distributed, and intake was calculated to
produce a 500 kcal/day energy deﬁcit. Insulin action was as-
sessed by the euglycemic clamp and insulin secretion by meal
tolerance test. Body composition, adipokine levels, and vascular
compliance by pulse-wave analysis were also measured.
RESULTS—Signiﬁcant weight loss occurred in both groups
(P  0.01), with no difference between groups (P  0.40).
Peripheral glucose uptake increased, but there was no difference
between groups (P  0.28), and suppression of endogenous
glucose production was also similar between groups. Meal
tolerance–related insulin secretion decreased with weight loss
with no difference between groups (P  0.71). The change in
overall systemic arterial stiffness was, however, signiﬁcantly
different between diets (P  0.04); this reﬂected a signiﬁcant
decrease in augmentation index following the low-fat diet, com-
pared with a nonsigniﬁcant increase within the low-carbohydrate
group.
CONCLUSIONS—This study demonstrates comparable effects
on insulin resistance of low-fat and low-carbohydrate diets
independent of macronutrient content. The difference in augmen-
tation index may imply a negative effect of low-carbohydrate
diets on vascular risk. Diabetes 58:2741–2748, 2009
T
he worldwide pandemic of overweight/obesity is
a major public health concern and is strongly
linked to the rising prevalence of diabetes and
cardiovascular disease (1,2). While excess ca-
loric intake and positive energy balance are clearly asso-
ciated with the development of overweight/obesity and its
consequences, it is also possible that dietary macronutri-
ent intake may be important, in particular increased levels
of sugar or fat (3,4).
Insulin resistance is a key feature of the pathophysiol-
ogy of obesity and diabetes and is also linked to the
development of atherosclerosis (5). In addition to overall
obesity, the anatomical distribution of adipose tissue
inﬂuences insulin resistance and diabetes risk, with the
highest risk in those with central or upper-body fat distri-
bution characterized by a large waist circumference (6).
Free fatty acids and adipocyte-derived proteins from
omental fat may provide the molecular link between
obesity and diabetes. Recently, retinol-binding protein 4
(RBP4) has been linked to insulin resistance, although
there is little information regarding the effects of dietary
modiﬁcation (7). In a recent study, serum RBP4 was
decreased following a carbohydrate-restricted diet but not
a low-fat diet (8).
The U.S. Diabetes Prevention Program and the Finnish
Diabetes Prevention Trial both demonstrated a powerful
effect of lifestyle intervention to reduce diabetes develop-
ment in high-risk subjects with impaired glucose tolerance
(9,10). Relatively modest weight loss (5–7% of initial body
weight) and moderate physical activity resulted in a 58%
reduction in the incidence of type 2 diabetes, which was
related to beneﬁcial effects on insulin resistance. The
lifestyle intervention achieved in these studies included a
hypocaloric low-fat diet. However, outside such rigorous
research studies, low-fat diets can be challenging for
patients and hard to maintain (11).
Rising levels of overweight/obesity have resulted in a
proliferation of weight loss diets, and there is currently a
vigorous debate regarding the optimal dietary macronutri-
ent composition that facilitates lasting and safe weight
loss (12,13). In recent years, low-carbohydrate diets have
attracted substantial media interest, presenting an attrac-
tive alternative to challenging lifestyle modiﬁcations (i.e.,
intentional caloric restriction and increased physical ac-
tivity). These diets are portrayed as scientiﬁcally sound
and limit carbohydrate amount and type to achieve unin-
tentional calorie reduction through blunting appetite. Re-
From the
1Regional Centre for Endocrinology and Diabetes, Royal Victoria
Hospital, Belfast, U.K.; and the
2Nutriton and Metabolism Group, The
Queen’s University of Belfast, Belfast, U.K.
Corresponding author: Steven J. Hunter, steven.hunter@belfasttrust.hscni.net.
Received 22 January 2009 and accepted 19 August 2009. Published ahead of
print at http://diabetes.diabetesjournals.org on 31 August 2009. DOI:
10.2337/db09-0098. Clinical trial reg. no. ISRCTN85769730.
U.B. and M.S. contributed equally to this article.
© 2009 by the American Diabetes Association. Readers may use this article as
long as the work is properly cited, the use is educational and not for proﬁt,
and the work is not altered. See http://creativecommons.org/licenses/by
-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked “advertisement” in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
ORIGINAL ARTICLE
diabetes.diabetesjournals.org DIABETES, VOL. 58, DECEMBER 2009 2741striction of carbohydrate has also been shown to be
effective in controlling blood glucose and insulin levels
(14). As low-carbohydrate diets are generally associated
with reciprocal increases in fat consumption, which has
been linked to insulin resistance and lipid abnormalities,
there are concerns that this may offset the beneﬁts of
weight reduction (15). It is also possible that different
weight loss strategies exert varying effects on regional
adiposity and adipokine levels, which may inﬂuence the
metabolic effects of weight loss.
To investigate the effects of different weight loss strat-
egies, we performed an 8-week randomized controlled
trial to directly compare a low-carbohydrate hypocaloric
diet (20% energy from carbohydrate, 60% energy from fat)
with a low-fat hypocaloric diet (60% energy from carbohy-
drate, 20% energy from fat) in overweight/obese subjects.
The primary outcome variable, insulin resistance, was
assessed using the euglycemic-hyperinsulinemic clamp
combined with isotope dilution techniques. Secondary
outcomes included change in body composition, meal
tolerance–related insulin secretion, vascular compliance,
plasma leptin, and RBP4 levels.
RESEARCH DESIGN AND METHODS
Twenty-seven overweight or obese, but otherwise healthy, male and female
volunteers (BMI 27 kg/m
2) were recruited. Exclusion criteria included
diabetes, use of a weight loss diet in the previous 6 months, pregnancy, or
signiﬁcant cardiac disease. Due to the use of radioisotopes as part of the
assessments, women of childbearing age were excluded if they were not using
effective contraception. All subjects gave written informed consent, and the
protocol was approved by the research ethics committees of Northern Ireland
and the Administration of Radioactive Substances Advisory Committee.
Habitual dietary intake was assessed at baseline using a 4-day food diary
(including at least 1 weekend day). Thereafter, a parallel-group randomized
controlled trial design was used to assign volunteers to an 8-week period of
calorie restriction, during which they consumed one of two diets. Volunteers
were randomized in blocks of four using a random number generator to
ensure that equal numbers of volunteers received the low-carbohydrate and
low-fat diets. Throughout the intervention, volunteers were advised to main-
tain their usual level of physical activity and keep other lifestyle factors
unchanged. In addition, each volunteer took a standard multivitamin and
mineral tablet.
Volunteers attended the Regional Centre for Endocrinology and Diabetes
on two separate occasions (at 0745 h following an overnight fast) for baseline
assessment. On the ﬁrst occasion, anthropometric measurements and fasting
blood samples were taken (for determination of plasma glucose, insulin,
C-peptide, A1C, renal function, lipids, leptin, and RBP4). Arterial stiffness (by
pulse-wave analysis) and insulin secretion (during a meal tolerance test) were
also assessed. On the second occasion, insulin resistance was assessed by the
euglycemic-hyperinsulinemic clamp combined with isotope dilution tech-
niques. Whole-body dual-energy X-ray absorptiometry (DEXA) scanning was
also performed (Lunar Prodigy scanner; GE Medical Systems, Madison, WI) in
conjunction with Encore 2002 software. At the end of the 8-week dietary
intervention, the baseline measurements were repeated.
Dietary intervention. A 7-day cyclic menu was formulated for both diets
using the dietary analysis program WISP (Weighed Intake Software Program;
Tinuviel Software, Warrington, U.K.). The low-carbohydrate and low-fat diets
were matched for protein (20% of energy) and ﬁber (18 g/day) but varied in
carbohydrate (20 vs. 60% of total energy) and total fat content (60 vs. 20% of
energy), respectively. The low-fat diet was also designed to derive an
equivalent of 13% of energy from nonmilk extrinsic sugars, reﬂecting the
average amount consumed by adults in the U.K. (16). Diets were designed and
administered to produce a minimum weight loss of 0.5 kg per week. To attain
this goal, volunteers were fed their assigned diet with a calorie level deﬁcit of
500 kcal/day of estimated energy requirements (estimated by multiplying
basal metabolic rate by an appropriate activity factor) (17). Total energy
intakes were then modiﬁed (if required) on a weekly basis in 200-kcal
decrements to maintain 0.5 kg weight loss per week, while still adhering to
previously stated dietary proﬁles.
Volunteers attended on alternate days throughout the study and were
supplied with all appropriate foodstuffs (preweighed into daily portions) for
their particular diet. At each visit, compliance with the assigned diet was
assessed by a nutritionist (M.S.) who asked questions concerning the palat-
ability and acceptability of the diet. Foods that were “freely allowed” included
noncaloric beverages (water, diet cola, tea, and coffee) and seasoning. Alcohol
was not permitted. Representative menus for a single day on each diet are
shown in Table 1.
Assessment of insulin action. At the beginning and end of the dietary
period, insulin sensitivity was assessed by the euglycemic-hyperinsulinemic
clamp combined with infusion of [3-
3H] glucose as previously described
(18,19). A continuous insulin infusion was administered for2ha t2 . 0m U
kg
1  min
1 (0 time to 120 min).
Calculations. The non–steady-state equations of Steele et al. (20), as modi-
ﬁed by De Bodo et al. (21), were used to determine the glucose appearance
(Ra) and disappearance (Rd), assuming a pool fraction of 0.65 and extracel-
lular volume of 190 ml/kg. Rates of endogenous (hepatic) glucose production
were then calculated by subtraction of the exogenous glucose infusion rates
required to maintain euglycemia from isotopically determined rates of glucose
appearance.
Analytical techniques. Arterialized venous blood was used for all analyses
in the clamp studies. Plasma for measurement of glucose-speciﬁc activity was
deproteinized with barium hydroxide and zinc sulfate by the method of
Somogyi (22). Aliquots of tracer infusate and labeled exogenous glucose
infusion were spiked into nonradioactive plasma and processed in parallel to
allow calculation of [3-
3H] glucose infusion rates. Serum insulin was measured
by enzyme-linked immunosorbent assay (ELISA) (Abbot IMx; Abbott Labora-
tories, Berkshire, U.K.). Glucose was measured using an automated glucose
oxidase method using a Beckman Glucose Analyser 2. Commercial kits were
used to measure C-peptide (Dako Diagnostics, Ely, U.K.) and nonesteriﬁed
free fatty acids (Wako Chemicals, Neuss, Germany).
Adipokine measurement. Plasma levels of leptin and RBP4 were deter-
mined using commercially available sandwich ELISAs, according to the
manufacturer’s instructions (DRG Instruments, Marburg, Germany). Leptin
assays were carried out on the Triturus EIA Analyser system (Girfols,
TABLE 1
Sample menus for a typical day on each intervention diet
Meal Low-carbohydrate diet (7.7 MJ) Low-fat diet (7.6 MJ)
Breakfast Scrambled eggs (40 g); bacon rasher, fat trimmed, grilled
(20 g); hash brown, grilled (45 g)
Cornﬂakes (40 g), bran-based cereal (7 g), semiskimmed
milk (200 g), pineapple juice (250 g)
Lunch Wholemeal bread (72 g), cooked ham (30 g), mayonnaise
(25 g)
Wholemeal bread (72 g); cooked ham (60 g);
mayonnaise, reduced calorie (13 g); cheddar cheese,
reduced fat (20 g)
Dinner Potatoes, in skins, boiled (145 g); chicken breast in
crumbs, baked (140 g); peas, boiled (95 g); carrots,
boiled (70 g); gravy instant granules (4 g)
Potatoes, in skins, boiled (260 g); chicken breast in
crumbs, baked (120 g); peas, boiled (50 g); gravy
instant granules (5 g);
Additional
foods Peanuts, roasted and salted (40 g); Brazil nuts (30 g);
butter (21 g); cheddar cheese (44 g);
Chocolate mousse, low fat (55 g); apple (153 g); jaffa
cake (13 g); cola (150 g); chewy cereal bar (23 g);
fruit yogurt, low fat (150 g); white bread, toasted
(27g); strawberry jam (10 g); semiskimmed milk
(300 g)
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8.5% for leptin and RBP4, respectively.
Assessment of insulin secretion. Insulin secretion was assessed by a meal
tolerance test. After basal samples, volunteers consumed a liquid meal over 15
min (Ensure Plus; Abbott Nutrition, Kent, U.K.) standardized to body weight
(10 kcal/kg). The meal provided 57.0% energy from carbohydrate, 28.2%
energy from fat, and 14.8% energy from protein. Blood samples (for determi-
nation of insulin, C-peptide, glucose, and triglycerides) were taken every 30
min for the ﬁrst hour and then every hour for the next 3 h.
Arterial stiffness. Arterial stiffness was measured using pulse-wave analysis
(model SCOR-Px; PWV Medical, Sydney, Australia) as described previously
(18,23,24). The augmentation index (AIx, expressed as a percentage) was
deﬁned as the ratio of augmentation to pulse pressure and was used to
estimate overall systemic arterial stiffness.
Statistical analysis. Statistical analysis was performed using SPSS 13.0 for
Windows (SPSS, Chicago, IL). Results are expressed as means  SD.
Independent-samples t tests were used to compare the two groups at baseline.
Within-group changes in end points were assessed by using paired-samples t
tests. Repeated-measures ANOVA with diet (i.e., low carbohydrate versus low
fat) was set as a between-subject effect, and time (before diet versus after
diet) as a within-subject effect was used to compare responses over time in
both groups. The study (n  12 per diet group) had a 90% power (with P 
0.05; two tailed) to detect a 3.5 mol  kg
1  min
1 (10%) difference in
insulin action change between the two groups.
RESULTS
A total of 24 volunteers (15 female and 9 male subjects)
successfully completed the intervention. The baseline
clinical and anthropometric characteristics of the sub-
jects completing the study (n  12 assigned to the
low-carbohydrate diet [7 female/5 male] and n  12 [8
female/4 male] assigned to the low-fat diet) are given in
Table 2. Volunteers were, on average, obese but were
normotensive with normal fasting lipid proﬁles. The mean
fasting plasma glucose for both groups was toward the
upper limit of normal. Although glucose tolerance tests
were not performed, the mean fasting plasma glucose of
5.6 mmol/l was in the pre-diabetes range, consistent with
an increased risk for development of diabetes. Baseline
clinical and anthropometric variables did not differ signif-
icantly between the two groups.
Analysis of habitual dietary intake from 4-day food
diaries collected at baseline (Table 3) showed that mean
consumption of energy and nutrient intakes were similar
between both dietary groups. The total dietary energy
provided by carbohydrate and fat intake (at baseline) was
41 and 40%, respectively, suggesting that volunteers’
diets were slightly lower in carbohydrate (by 8%) and
higher in fat (by 4%) than average intakes reported for
the adult population of the U.K. (16). Daily intakes of
energy and nutrients consumed by volunteers during the
intervention period for the low-carbohydrate and low-fat
diets, respectively, are displayed in Table 4. Diets provided
comparable amounts of energy and were matched for
protein and ﬁber intake but in line with the study protocol
were signiﬁcantly different in terms of the proﬁle of the
TABLE 2
Baseline clinical and anthropometric characteristics of volun-
teers assigned to a low-carbohydrate (n  12) or low-fat diet
(n  12)
Low-carbohydrate
diet Low-fat diet P*
Age (years) 37.1  8.9 40.5  10.4 0.40
Height (m) 1.68  0.10 1.67  0.12 0.25
Weight (kg) 97.7  14.4 91.5  11.1 0.78
BMI (kg/m
2) 34.5  4.2 32.8  3.0 0.28
Systolic blood
pressure (mmHg) 122  12 127  15 0.41
Diastolic blood
pressure (mmHg) 70  77 7  9 0.06
Waist circumference
(cm) 107.0  11.1 105.1  9.0 0.66
Waist-to-hip ratio 0.92  0.08 0.92  0.09 0.90
Fasting plasma
glucose (mmol/l) 5.5  0.8 5.6  0.5 0.74
Fasting insulin
(mU/l) 12.5  6.2 11.4  6.1 0.65
A1C (%) 5.3  0.3 5.4  0.3 0.79
Total cholesterol
(mmol/l) 4.65  1.06 5.00  0.99 0.41
LDL cholesterol
(mmol/l) 2.47  1.08 2.85  0.88 0.35
HDL cholesterol
(mmol/l) 1.47  0.40 1.40  0.39 0.68
Triglycerides
(mmol/l) 1.59  0.55 1.55  0.90 0.90
Data are means  SD. *Between-group comparisons analyzed by
independent-samples t test.
TABLE 3
Baseline daily energy and nutrient intakes of volunteers assigned
to a low-carbohydrate (n  12) or low-fat diet (n  12)
Low-carbohydrate
diet
Low-fat
diet P*
Energy (MJ/day) 11.0  2.5 9.5  1.4 0.11
Carbohydrate (total
energy %) 40  74 1  7 0.92
Starch 25  32 4  5 0.42
Sugars 15  71 7  4 0.46
Nonmilk extrinsic
sugar 8  61 1  4 0.29
Protein (total energy %) 15  21 6  4 0.42
Fat (total energy %) 40  83 9  6 0.66
Saturated fat 15  61 3  3 0.34
Monounsaturated fat 13  31 2  3 0.69
Polyunsaturated fat 6  27  2 0.14
Alcohol (total energy %) 4  24  1 0.91
Englyst ﬁbre (g/day) 18  51 4  4 0.71
Data are means  SD. *Between-group comparisons analyzed by
independent-samples t test.
TABLE 4
Intervention intakes of energy and nutrients consumed by sub-
jects assigned to a low-carbohydrate (n  12) or low-fat diet
(n  12)
Low-carbohydrate
diet
Low-fat
diet P*
Energy (MJ/day) 7.9  1.8 7.1  1.2 0.25
Carbohydrate (total
energy %) 20  0.1 60  0.1 0.01
Starch 13  1.9 35  1.5 0.01
Sugars 7  1.8 26  1.4 0.01
Nonmilk extrinsic
sugar 1  0.8 16  0.1 0.01
Protein (total energy %) 20  0.1 20  0.1 0.66
Fat (total energy %) 60  0.1 20  0.1 0.01
Saturated fat 21  3.0 7  0.7 0.01
Monounsaturated fat 21  1.7 6  0.5 0.01
Polyunsaturated fat 13  2.3 3  0.4 0.01
Englyst ﬁbre (g/day) 18  0.1 18  0.1 0.13
Data are means  SD. *Between-group comparisons analyzed by
independent-samples t test.
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constant throughout the study.
Weight loss and body composition. The results in Table
5 indicate that the mean weight loss from baseline was
similar between the two diet groups (P  0.40). The mean
weight loss following the low-carbohydrate and low-fat
dietary interventions represented 7.6 and 7.1% of initial
body weight, respectively (P  0.01 within each group).
There was no signiﬁcant difference in the change in either
waist circumference (reﬂecting central adiposity) or per-
centage body fat (determined by DEXA) between the diet
groups (P  0.63 and P  0.77, respectively), although
each signiﬁcantly decreased compared with baseline (P 
0.05) following both dietary regimens.
Clamp studies. Plasma glucose was maintained at a
constant level by exogenous glucose infusion with a CV
5% as the plateau for each clamp. There was no
difference in the change in glucose infusion rate from
baseline between the two diets (P  0.28). Within the
low-carbohydrate diet group, the glucose infusion rate
signiﬁcantly increased from baseline (23.5  7.4 to
28.3  6.9 mol  kg
1  min
1 postintervention, P 
0.02) (Table 5). In the low-fat diet group, no signiﬁcant
pre- to postdifference was observed in the glucose
infusion rate (28.3  9.5 mol  kg
1  min
1 at baseline to
30.2  8.5 mol  kg
1  min
1 postintervention, P  0.39).
Fasting (basal) endogenous glucose production was simi-
lar following both diets and suppressed to a comparable
degree during hyperinsulinemia (90–120 min) (Fig. 1).
There was no difference in serum nonesteriﬁed fatty acid
suppression when comparing baseline and end studies
within the diet groups (low-carbohydrate group P  0.73 and
low-fat group P  0.47). On comparison, between the groups
there was no difference in suppression at the end of the study
(P  0.72) (Table 6).
Metabolic proﬁles. Changes in fasting plasma glucose,
A1C, and fasting serum insulin were not signiﬁcantly
different when the diets were compared (P  0.69, 0.36,
and 0.17, respectively). Within the low-carbohydrate and
low-fat diet group, fasting serum insulin signiﬁcantly de-
creased (P  0.01 and P  0.02, respectively), whereas
fasting plasma glucose remained unchanged (P  0.78 and
P  0.32, respectively). The change in A1C was only
signiﬁcant within the low-carbohydrate diet group (P 
0.01) (Table 5).
The only signiﬁcant difference in lipid proﬁles between
the two diets was the change in triglycerides (P  0.01).
This difference reﬂected a signiﬁcant reduction in triglyc-
erides after the low-carbohydrate diet (1.59  0.55 to
0.91  0.33 mmol/l postintervention, P  0.01). Within the
low-fat diet group, total, LDL, and HDL cholesterol did,
however, decrease signiﬁcantly following the intervention
(P  0.05).
Meal tolerance tests. There was no signiﬁcant difference
in the change in insulin secretion from baseline between
diets (P  0.71). There was a signiﬁcant reduction in meal-
related insulin secretion following the low-carbohydrate diet
(P  0.05), whereas following the low-fat diet there was a
similar trend toward a reduction, which was not statistically
TABLE 5
Changes in anthropometric measurements, body composition, and metabolic variables in response to a hypocaloric low-carbohydrate
(n  12) and low-fat diet (n  12)
Variable
Low-carbohydrate diet Low-fat diet Between-
group P† Before diet After diet P* Before diet After diet P*
Weight (kg) 97.7  14.4 90.3  12.9 0.01 91.5  11.1 85.0  11.2 0.01 0.40
BMI (kg/m
2) 34.5  4.2 31.9  3.9 0.01 32.8  3.0 30.5  3.0 0.01 0.51
Waist circumference (cm) 107.0  11.1 102.4  10.4 0.01 105.1  9.0 100.0  8.5 0.01 0.63
DEXA fat body mass (kg) 38.8  8.5 34.9  9.0 0.01 37.3  6.5 33.5  6.6 0.01 0.89
DEXA lean body mass (kg) 54.4  11.2 51.6  9.8 0.01 50.3  9.9 48.6  9.8 0.01 0.19
DEXA % body fat 40.5  6.6 38.9  7.2 0.03 41.5  6.4 39.7  7.1 0.01 0.77
Fasting plasma glucose (mmol/l) 5.5  0.8 5.4  0.7 0.78 5.6  0.5 5.4  0.4 0.32 0.69
Fasting serum insulin (mU/l) 12.5  6.2 7.4  3.8 0.01 11.4  6.1 9.0  4.4 0.02 0.17
A1C (%) 5.3  0.3 5.2  0.003 0.01 5.4  0.3 5.3  0.4 0.41 0.36
GIR (mol  kg
1  min
1) 23.5  7.4 28.3  6.9 0.02 28.3  9.5 30.2  8.5 0.39 0.28
Total cholesterol (mmol/l) 4.65  1.06 4.05  0.82 0.06 5.00  0.99 4.12  1.00 0.01 0.43
LDL cholesterol (mmol/l) 2.46  1.08 2.1  0.78 0.05 2.85  0.88 2.41  0.76 0.01 0.64
HDL cholesterol (mmol/l) 1.47  0.40 1.35  0.32 0.11 1.40  0.39 1.15  0.30 0.01 0.12
Triglycerides (mmol/l) 1.59  0.55 0.91  0.33 0.01 1.55  0.90 1.43  0.57 0.44 0.01
Leptin (ng/ml) 35.6  20.5 18.9  18.3 0.01 36.1  18.7 22.6  15.5 0.01 0.30
Retinol binding protein 4 (g/ml) 30.6  4.6 26.5  10.7 0.18 30.2  14.6 24.0  5.2 0.11 0.63
Data are means  SD. *Within-group comparisons analyzed by paired-samples t test. †Between-group comparisons analyzed by ANOVA. GIR,
glucose infusion rate during euglycemic clamp.
0
2
4
6
8
10
12
14
Basal 90-120 min 90-120 min Basal
E
n
d
o
g
e
n
o
u
s
 
G
l
u
c
o
s
e
P
r
o
d
u
c
t
i
o
n
 
(
u
m
o
l
/
k
g
/
m
i
n
)
Before Diet After Diet
Low-carbohydrate diet
Low-fat diet
FIG. 1. Endogenous glucose production during clamp studies.
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from baseline with either the low-fat or low-carbohydrate diet
(P  0.53 and P  0.23, respectively, data not shown); conse-
quently, there was no difference in the change from baseline in
glucose levels between diets (P  0.98). Likewise, there was no
difference in change between the diets for postprandial triglyc-
eride levels (P  0.97, data not shown) (Fig. 2 and the online
appendix [available at http://diabetes.diabetesjournals.org/cgi/
content/full/db09-0098/DC1]).
Adipokines. Plasma leptin levels decreased signiﬁcantly
within each diet group (P  0.01), but changes between
groups were not signiﬁcant (P  0.30). Changes in plasma
RBP4 were not signiﬁcant within (low-carbohydrate group
P  0.18 and low-fat group P  0.11) or between diet
groups (P  0.63) (Table 5).
Hemodynamic studies. Improvements in systolic and
diastolic blood pressure (both P  0.05) were similar
between the two diet groups (P  0.91 and 0.73, respec-
tively). The change in AIx was, however, signiﬁcantly
different (P  0.04) when the two diets were directly
compared. This difference related to a signiﬁcant decrease
in AIx following the low-fat diet (mean change in AIx at the
end of 8 weeks 3.75  5.53%, P  0.04) compared with a
nonsigniﬁcant increase within the low-carbohydrate group
(mean change in AIx at the end of 8 weeks  2.17  7.22%,
P  0.32). Other indexes of arterial stiffness (including
augmentation, time-to-wave reﬂection, and brachial pulse-
wave velocity) were not signiﬁcantly different between or
within diet groups (Table 7).
DISCUSSION
This study demonstrates that under hypocaloric condi-
tions, a low-carbohydrate diet (60% fat, 20% carbohydrate)
and a low-fat diet (60% carbohydrate, 20% fat) were equally
effective in producing weight loss in overweight/obese
adults. The observed weight loss (7%) with both hypoca-
loric diets is comparable to that achieved in both the
Diabetes Prevention Program and the Finnish Diabetes
Prevention Trial (8,9). In these trials, relatively modest
weight loss (5–7% of initial body weight) and moderate
physical activity resulted in a 58% reduction in the 4-year
incidence of type 2 diabetes (in high-risk individuals with
impaired glucose tolerance). The current study demon-
strated no difference between a low-fat and a low-carbo-
hydrate weight reduction diet in the effect on insulin
sensitivity, which suggests a comparable effect on preven-
tion of diabetes, independent of dietary macronutrient
composition. However, it should be noted that subjects
enrolled in the current study had mean fasting plasma
glucose at the upper end of the normal range (consistent
with pre-diabetes and hence increased risk for develop-
ment of diabetes), a distinction from the diabetes preven-
tion trials that enrolled subjects with impaired glucose
tolerance.
Previous studies (25,26) have demonstrated more rapid
weight loss with low-carbohydrate diets. In this study, we
did not restrict carbohydrate sufﬁciently to induce keto-
genesis, and carbohydrate intake was maintained constant
throughout the study, rather than the gradual increase in
carbohydrate intake advocated by the Atkins diet. Further-
more, the caloric deﬁcit was the same for both diets, and
this may explain the comparable weight loss proﬁles.
A strength of the present study is the randomized
controlled design and rigorous dietetic supervision. Menu
plans were individually formulated to each volunteer’s
like/dislikes, and all meals were provided, ensuring that
the intended composition was supplied to all volunteers.
Although it is impossible to measure compliance with the
diets under study, volunteers were reviewed every 2–3
days throughout the study and questioned regarding pal-
atability and compliance with food provided. The intended
weight loss was achieved, and this is further evidence of
careful nutritional supervision and planning.
The primary outcome measure of insulin sensitivity
was assessed using the gold standard hyperinsulinemic-
euglycemic clamp combined with isotope dilution tech-
niques. The high-dose insulin infusion used during the
euglycemic clamp results in maximally stimulated glucose
uptake and reﬂects skeletal muscle or peripheral insulin
sensitivity. In our study group as a whole (n  24),
peripheral insulin sensitivity signiﬁcantly improved (P 
0.03), but the change was only signiﬁcant within the
low-carbohydrate diet (P  0.02), and there was no
signiﬁcant difference between groups (P  0.28). The
study was powered to exclude a 10% difference in insulin
TABLE 6
Changes in serum nonesteriﬁed fatty acid levels at basal state (30 to 0 min) and during insulin infusion (90–120 min) in response
to a hypocaloric low-carbohydrate (n  12) and low-fat diet (n  12)
Variable
Low-carbohydrate diet Low-fat diet Between-
group P† Before diet After diet P* Before diet After diet P*
Nonesteriﬁed fatty acids (mol/l) at basal
state (30 to 0 min)‡ 706  160 715  194 0.89 698  190 796  209 0.09 0.33
Nonesteriﬁed fatty acids (mol/l) during
insulin infusion (90–120 min)‡ 180  58 213  82 0.10 244  144 265  210 0.34 0.78
Data are means  SD. *Within-group comparisons analyzed by paired-samples t test. †Between-group comparisons analyzed by ANOVA.
‡Measured in clamp assessment.
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FIG. 2. Serum insulin levels during meal tolerance tests at baseline and
following the hypocaloric low-carbohydrate and low-fat diets.
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relevant impact.
There was also no signiﬁcant effect of altering macro-
nutrient content on either fasting hepatic glucose produc-
tion or its suppression during the clamp studies, which are
both measures of hepatic insulin resistance, which is
recognized as an early abnormality in type 2 diabetes (20).
Furthermore, we found no difference in either fasting
levels of nonesteriﬁed fatty acid concentrations or their
suppression during hyperinsulinemia, indicating no differ-
ential effect on adipose tissue insulin action and suppres-
sion of lipolysis.
Previous studies suggest that improvement in insulin
sensitivity after consumption of a low-carbohydrate diet is
similar to that seen on a low-fat diet (when associated with
weight loss) (25,26). However, this is based on suboptimal
methods such as the quantitative insulin sensitivity check
index (QUICKI). Diets high in total fat and saturated fat
(relative to monounsaturated fat) have been shown to
impair insulin sensitivity (15,27). The mechanism of this
effect is not clearly understood, although it is possible that
dietary modiﬁcation modulates changes in the fatty acid
composition of cell membranes, thus inﬂuencing insulin
receptor binding/activity as well as ion permeability and
cell signaling (28). However, no appreciable differences
were found between diet groups in the current study using
the reference standard technique to assess insulin sensi-
tivity. It is possible that the effects of weight loss overcame
any lesser effect of dietary macronutrient intake.
Abnormalities of insulin secretion may also contribute
to the development of diabetes (29). We demonstrated a
comparable effect of the two diets on both fasting and
meal tolerance–related insulin secretion. Given the similar
effects on insulin resistance, we conclude that both diets
exert equivalent effects on prevention of diabetes, primar-
ily related to the degree of weight reduction. The compa-
rable reduction in BMI was largely attributable to a
decrease in fat mass, mainly from the central body area, as
demonstrated by both DEXA scanning and a reduction in
waist circumference. Increased central body fat is associ-
ated with insulin resistance and the metabolic syndrome,
and the reduction in central adiposity was related to the
improvement in insulin sensitivity, which in turn might be
expected to reduce the risk of type 2 diabetes and also
cardiovascular risk (30).
As expected, the low-fat diet decreased both LDL and
HDL cholesterol. Although the low-carbohydrate diet did
not decrease LDL cholesterol, it was not associated with a
signiﬁcant decline in HDL cholesterol. Given the estab-
lished evidence that LDL lowering reduces the risk of
coronary heart disease, the lack of a decrease may be of
concern. In contrast to the lack of a change in LDL and
HDL in response to the low-carbohydrate diet, there was a
signiﬁcant reduction in triglycerides within this group
compared with no signiﬁcant change within the low-fat
group. This response has been consistently reported in
other studies comparing a low-carbohydrate and low-fat
weight reduction diet (12). It has been speculated that this
result is due to a combination of a decrease in the VLDL
production rate and an increase in triglyceride removal
from the blood (31). Previous studies (32,33) indicate that
increased triglycerides are an independent risk factor for
cardiovascular disease, although it is impossible to predict
the overall effect of the lipid changes with the low-
carbohydrate diet. Further examination of the lipid sub-
fraction proﬁle may help elucidate the effects of the
dietary regimens on lipid metabolism. Indeed, previous
studies have suggested that low-carbohydrate diets in-
crease LDL particle size and decrease small dense LDL
particles (34).
A major concern associated with low-carbohydrate diets
is that the reciprocal increase in dietary fat intake, partic-
ularly if this includes saturated and trans fat, may have
detrimental effects on cardiovascular risk. In addition to
examining cardiovascular risk factors, we also assessed
arterial stiffness, which is increasingly recognized as an
important determinant of cardiovascular risk (35). Stiffen-
ing of the arterial tree increases the velocity and amplitude
of the reﬂected pulse waves from the periphery, with the
result that larger waves return to the aorta earlier. This
augments central systolic pressure, which increases left
ventricular workload and myocardial oxygen demand. In
the present study, the change in AIx (a measure of overall
systemic stiffness) was signiﬁcantly more favorable with
the low-fat diet, with a signiﬁcant and favorable reduction
in AIx compared with a nonsigniﬁcant increase in the
low-carbohydrate diet group. A post hoc power analysis
revealed that the study had 90% power to detect a be-
tween-diet difference of 9% for augmentation index. Al-
though an isolated ﬁnding in the present study, this is
consistent with a recent report that demonstrated a reduc-
tion in ﬂow-mediated dilation following a low-carbohydrate
diet compared with an increase after a low-fat diet (36). It
is possible that the high fat content of a low-carbohydrate
diet exerts detrimental effects on endothelial function,
which raises concerns regarding the long-term safety and
efﬁcacy of low-carbohydrate diets.
Changes in leptin levels were comparable in both diets
and related to weight loss rather than any speciﬁc effect of
dietary macronutrient composition (37). Recently, RBP4
has been proposed as an adipocyte-derived factor that may
regulate insulin sensitivity (7). Diet-induced changes in
RBP4 were not responsible for the change in insulin
sensitivity in the current study, as neither the low-fat nor
TABLE 7
Changes in hemodynamic variables in response to a hypocaloric low-carbohydrate (n  12) and low-fat diet (n  12)
Variable
Low-carbohydrate diet Low-fat diet Between-
group P† Before diet After diet P* Before diet After diet P*
Systolic blood pressure (mmHg) 122  12 114  10 0.01 127  15 119  11 0.03 0.91
Diastolic blood pressure (mmHg) 70  76 5  8 0.03 77  97 1  7 0.01 0.73
Augmentation (mm/Hg) 7.4  7.1 8.4  5.4 0.44 9.2  7.4 8.3  7.8 0.37 0.24
Aortic augmentation index (%) 12.3  12.2 14.5  11.9 0.32 17.0  14.4 13.3  16.3 0.04 0.04
Time-to-wave reﬂection (ms) 151  20 156  25 0.50 152  23 161  29 0.05 0.55
Brachial pulse-wave velocity (ms) 8.3  0.6 8.2  0.7 0.61 8.1  1.7 8.1  1.5 1.00 1.00
Data are means  SD. *Within-group comparisons analyzed by paired-samples t test. †Between-group comparisons analyzed by ANOVA.
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icant effect on circulating concentrations. This is in keep-
ing with one previous study (38), but in another study (7)
changes in RBP4 were associated with an improvement in
insulin sensitivity. Differences in study design may explain
these conﬂicting ﬁndings (e.g., the latter study utilized an
exercise intervention and examined both normal subjects
and those with type 2 diabetes).
One limitation of this study is that the subjects were of
white Western European origin and did not have signiﬁ-
cant baseline abnormalities. These factors can alter base-
line insulin sensitivity and may inﬂuence interventional
responses. In addition, to allow conclusions to be drawn
about varying the carbohydrate and fat content of hypoca-
loric diets, overall calorie intake was controlled rather
than allowing ad libitum consumption, thus allowing pro-
tein intake and ﬁber to be accurately matched in both
diets. Furthermore, the type of fat in a low-carbohydrate
diet (i.e., saturated/trans fat versus mono/polyunsaturated
fat) may be important (39). The conclusions from these
data must therefore be limited to the described over-
weight/obese group consuming a weight loss diet in a
carefully controlled situation.
In conclusion, under the conditions of this study, a
low-carbohydrate hypocaloric diet was as effective as a
low-fat hypocaloric diet in achieving signiﬁcant weight
loss during an 8-week period. The 7% weight loss with both
diets is comparable with the magnitude seen in diabetes
prevention studies and is signiﬁcant in terms of disease
prevention (9,10). Both diets promoted weight loss from
the central body region and were associated with compa-
rable effects on insulin sensitivity. There was, however, a
signiﬁcant difference in AIx, a measure of vascular com-
pliance, between the two diets that was not explained by
changes in conventional vascular risk factors. This obser-
vation is of concern and, if conﬁrmed, would suggest a
potentially negative effect of a low-carbohydrate diet on
long-term vascular health. Currently, supported by evi-
dence from long-term trials, we believe that a low-fat diet
should remain the preferred diet for diabetes prevention.
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